Recent discussions on X regarding STERIS plc (STE) have centered around the company's stock performance and institutional investment activity. Several posts noted recent moves by investment firms, with some increasing their stakes in the medical equipment provider during the second quarter, signaling confidence in its growth potential. The chatter reflects curiosity about whether these investments will translate into sustained upward momentum for the stock.
Additionally, there’s a focus on STERIS’s role in the healthcare sterilization and infection prevention space, with users highlighting its strategic acquisitions as a potential driver for future revenue. While opinions vary, the general tone leans toward cautious optimism as investors await further updates on financial performance. The discussion underscores a keen interest in how STERIS navigates a competitive market landscape.
Note: This discussion summary was generated from an AI condensation of post data.
STERIS plc Congressional Stock Trading
Members of Congress have traded $STE stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $STE stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 3 times. They made 2 purchases worth up to $30,000 on 09/18, 09/11 and 1 sale worth up to $15,000 on 06/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
STERIS plc Insider Trading Activity
STERIS plc insiders have traded $STE stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $STE stock by insiders over the last 6 months:
- DANIEL A CARESTIO (President and CEO) has made 0 purchases and 3 sales selling 17,626 shares for an estimated $4,275,338.
- CARY L MAJORS (SVP and President, Healthcare) has made 0 purchases and 2 sales selling 12,828 shares for an estimated $3,208,025.
- KAREN L BURTON (VP & CAO) sold 7,900 shares for an estimated $1,909,667
- MOHSEN SOHI sold 4,110 shares for an estimated $994,455
- CYNTHIA L FELDMANN sold 3,495 shares for an estimated $844,252
- RENATO TAMARO (V.P. & Corporate Treasurer) sold 3,204 shares for an estimated $798,564
- JOHN ADAM ZANGERLE (Sr. VP, Gen Counsel, and Sec.) has made 0 purchases and 2 sales selling 1,978 shares for an estimated $477,581.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
STERIS plc Hedge Fund Activity
We have seen 440 institutional investors add shares of STERIS plc stock to their portfolio, and 314 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WCM INVESTMENT MANAGEMENT, LLC removed 2,405,472 shares (-53.4%) from their portfolio in Q2 2025, for an estimated $577,842,483
- BLACKROCK, INC. removed 568,172 shares (-6.2%) from their portfolio in Q2 2025, for an estimated $136,486,277
- ORBIS ALLAN GRAY LTD added 556,088 shares (+36.0%) to their portfolio in Q2 2025, for an estimated $133,583,459
- JPMORGAN CHASE & CO removed 368,481 shares (-35.3%) from their portfolio in Q2 2025, for an estimated $88,516,505
- INVESCO LTD. added 297,076 shares (+32.2%) to their portfolio in Q2 2025, for an estimated $71,363,596
- GOLDMAN SACHS GROUP INC added 276,694 shares (+114.0%) to their portfolio in Q2 2025, for an estimated $66,467,432
- QUBE RESEARCH & TECHNOLOGIES LTD added 243,117 shares (+inf%) to their portfolio in Q2 2025, for an estimated $58,401,565
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
STERIS plc Analyst Ratings
Wall Street analysts have issued reports on $STE in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 08/08/2025
- JMP Securities issued a "Market Outperform" rating on 05/16/2025
- Stephens & Co. issued a "Overweight" rating on 05/15/2025
To track analyst ratings and price targets for STERIS plc, check out Quiver Quantitative's $STE forecast page.
STERIS plc Price Targets
Multiple analysts have issued price targets for $STE recently. We have seen 5 analysts offer price targets for $STE in the last 6 months, with a median target of $280.0.
Here are some recent targets:
- Patrick Wood from Morgan Stanley set a target price of $295.0 on 08/08/2025
- Brett Fishbin from Keybanc set a target price of $288.0 on 07/22/2025
- David Windley from Jefferies set a target price of $263.0 on 05/29/2025
- David Turkaly from JMP Securities set a target price of $280.0 on 05/16/2025
- Steven Etoch from Stephens & Co. set a target price of $250.0 on 05/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
